TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A review of clinical trials found that multivitamins most consistently raised blood levels of folate and vitamins B6 and B12. Evidence for improvements in health outcomes—including pregnancy measures and cognitive performance—varied, and the review did not assess study bias or rate the certainty of evidence.
A review of 103 clinical-trial reports found that multivitamins most consistently raised blood levels of folate and vitamins B6 and B12, but the evidence that those changes improve health outcomes was mixed. Published in the Journal of Dietary Supplements, the review also found that results differed by product, population and duration of use, leaving the overall benefits and risks difficult to generalize.
The researchers reviewed studies of oral tablets and capsules that provided at least half of the recommended or adequate intake for 14 or more vitamins and minerals, with at least two vitamins and two minerals. Eligible trials lasted at least two weeks and included more than 10 participants. The review covered primarily adults, with an exception for some prenatal studies in low- and middle-income countries that included younger participants.
Searches of PubMed, Scopus and the Cochrane Library through September 9, 2026, identified 5,263 records. After screening and citation searches, the authors included 157 publications: 103 primary intervention reports and 54 related publications, some based on the same trial populations. Blood measures showed the clearest recurring changes for folate and vitamins B6 and B12. Mineral responses, including those involving iron, zinc and iodine, were less consistent and depended on circumstances such as participants’ starting nutrient levels.
Some trials reported changes in pregnancy outcomes or cognitive test performance, but findings varied across groups and endpoints. The review also described mild digestive complaints, particularly with products containing iron or zinc, and adverse findings reported in some individual trials. The authors did not conduct a meta-analysis or assess risk of bias or certainty of evidence, so the review does not establish how large or dependable the reported effects are.
Nutrient Gains Do Not Guarantee Health Benefits
The distinction between a higher blood nutrient level and a meaningful improvement in health is central to interpreting the findings. A supplement may change a laboratory measure without preventing illness, improving daily functioning or extending life. The review found that clinical outcomes were not consistently improved even when nutrient levels rose.
That matters to consumers because multivitamins are widely used: the source report estimates that about one-third of U.S. adults take them, with use increasing with age. The review does not support treating all products or users as interchangeable. Formulations, baseline nutrition, life stage and medical circumstances can affect both potential benefit and risk.
Safety findings also require attention without overstating them. Some included studies reported mild digestive effects; the Physicians’ Health Study II reported modest increases in rash and nosebleeds, while the COSMOS trial reported increased gastrointestinal bleeding. Safety reporting varied among trials, so these reports do not describe a uniform risk for every product or user.
Products Worth Considering
Levoit Core 300S-P Smart Wi-Fi Air Purifier
Withings BPM Vision Blood Pressure Monitor with Wi-Fi and Bluetooth
Therabody JetBoots Prime Wireless Compression Boots – Short (under 29 inseam)
As an affiliate, we earn on qualifying purchases.
How Researchers Selected the Trials
The review focused on broad-spectrum multivitamins in tablets and capsules, not every product marketed as a multivitamin. It excluded, among other forms, fortified foods, powders, syrups, enteral nutrition and lipid-based formulations. Products also had to meet nutrient-count and intake thresholds, which means the conclusions may not apply to preparations outside those criteria.
Pregnancy findings included results from particular settings and comparisons, rather than evidence of a general benefit for every pregnancy. For example, the JiVitA-3 trial reported fewer low-birth-weight and preterm births with multiple micronutrients than with iron and folic acid, but no significant reduction in infant mortality through six months. The SUMMIT trial reported an 18% lower relative risk of early infant mortality. Those are separate trial findings, not proof that multivitamins prevent pregnancy complications broadly.
Other results were similarly specific. A two-week study among women with preeclampsia assessed multivitamins added to intravenous magnesium sulfate; it does not establish prevention of preeclampsia or benefits in uncomplicated pregnancies. In the CALERIE study, both randomized groups received multivitamins, limiting conclusions about their independent effect on anemia.
Limits of the Evidence Review
The review maps reported results but does not provide a pooled estimate of benefit. Because the researchers did not assess risk of bias or rate the certainty of evidence, readers cannot use this review alone to determine how reliable each finding is. Differences in formulations, populations, trial lengths and outcome measures also make direct comparisons difficult.
It remains unclear whether the observed nutrient changes lead to lasting health improvements for people who are not deficient, and which groups, if any, benefit most from particular formulations. The review also does not settle the balance of benefits and harms for an individual, whose medicines and health circumstances may matter. It notes that vitamin K can interfere with anticoagulants such as warfarin; people taking such medicines should consult a qualified healthcare professional before using a multivitamin.
What Future Trials Need to Establish
The review itself reports no new clinical trial or next scheduled milestone. The evidence gaps point to a need for better-designed studies that identify the exact formulation, participants’ baseline nutrient status, duration of use and clinically meaningful outcomes. More consistent safety reporting would also help researchers compare possible harms across products and populations.
For now, the reported findings support a narrow conclusion: some multivitamins raise certain nutrient levels, while evidence for broader health effects remains variable. Any individual decision about supplementation should take account of diet, life stage, medicines and health needs, with a healthcare professional consulted when relevant.
Key Questions
Which nutrient levels rose most consistently?
The review found the most consistent increases in circulating folate and vitamins B6 and B12. Results for other nutrients varied across studies and populations.
Did the review show that multivitamins improve overall health?
No broad improvement was established. Some trials reported benefits for selected pregnancy outcomes or cognitive tests, but findings varied, and higher nutrient levels did not consistently translate into better clinical outcomes.
What side effects were reported?
Some studies reported mild digestive complaints, particularly with iron- or zinc-containing products. Individual trials also reported other adverse findings, including modest increases in rash and nosebleeds in the Physicians’ Health Study II and increased gastrointestinal bleeding in COSMOS. Safety reporting differed across trials.
Can multivitamins affect prescription medicines?
The review notes that vitamin K may interfere with anticoagulants such as warfarin. People taking these medicines should consult a qualified healthcare professional before using a multivitamin.
How strong is the evidence?
The review included 103 primary intervention reports, but did not assess risk of bias, rate evidence certainty or conduct a meta-analysis. Its findings summarize the available studies but do not establish the size or reliability of benefits.
Source: news-medical.net
